Zhejiang Huahai Pharmaceutical Co Ltd (600521) - Total Assets
Based on the latest financial reports, Zhejiang Huahai Pharmaceutical Co Ltd (600521) holds total assets worth CN¥21.15 Billion CNY as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Zhejiang Huahai Pharmaceutical Co Ltd - Total Assets Trend (2000–2024)
This chart illustrates how Zhejiang Huahai Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Zhejiang Huahai Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Zhejiang Huahai Pharmaceutical Co Ltd's total assets of CN¥21.15 Billion consist of 41.9% current assets and 58.1% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 7.6% |
| Accounts Receivable | CN¥3.27 Billion | 16.2% |
| Inventory | CN¥3.41 Billion | 16.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥2.12 Billion | 10.5% |
| Goodwill | CN¥64.45 Million | 0.3% |
Asset Composition Trend (2000–2024)
This chart illustrates how Zhejiang Huahai Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang Huahai Pharmaceutical Co Ltd's current assets represent 41.9% of total assets in 2024, a decrease from 68.0% in 2000.
- Cash Position: Cash and equivalents constituted 7.6% of total assets in 2024, down from 35.3% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 2.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 16.9% of total assets.
Zhejiang Huahai Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Zhejiang Huahai Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩642.17 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp Preferred
KO:000105
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
|
Yuyu Pharma
KO:000220
|
Korea | ₩202.42 Billion |
|
Ildong Holdings Co Ltd
KO:000230
|
Korea | ₩813.62 Billion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
Zhejiang Huahai Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.32 | 1.40 | 2.26 |
| Quick Ratio | 0.74 | 0.79 | 1.44 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.11 Billion | CN¥2.30 Billion | CN¥3.63 Billion |
Zhejiang Huahai Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhejiang Huahai Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.48 |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | 8.9% |
| Total Assets | CN¥20.26 Billion |
| Market Capitalization | $3.70 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang Huahai Pharmaceutical Co Ltd's assets below their book value (0.18x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Zhejiang Huahai Pharmaceutical Co Ltd's assets grew by 8.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Zhejiang Huahai Pharmaceutical Co Ltd (2000–2024)
The table below shows the annual total assets of Zhejiang Huahai Pharmaceutical Co Ltd from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥20.26 Billion | +8.93% |
| 2023-12-31 | CN¥18.60 Billion | +2.47% |
| 2022-12-31 | CN¥18.15 Billion | +17.35% |
| 2021-12-31 | CN¥15.47 Billion | +19.07% |
| 2020-12-31 | CN¥12.99 Billion | +21.08% |
| 2019-12-31 | CN¥10.73 Billion | +3.49% |
| 2018-12-31 | CN¥10.37 Billion | +25.41% |
| 2017-12-31 | CN¥8.27 Billion | +22.90% |
| 2016-12-31 | CN¥6.73 Billion | +21.95% |
| 2015-12-31 | CN¥5.52 Billion | +22.29% |
| 2014-12-31 | CN¥4.51 Billion | +0.98% |
| 2013-12-31 | CN¥4.47 Billion | +38.84% |
| 2012-12-31 | CN¥3.22 Billion | +24.82% |
| 2011-12-31 | CN¥2.58 Billion | +25.45% |
| 2010-12-31 | CN¥2.05 Billion | +18.38% |
| 2009-12-31 | CN¥1.74 Billion | +14.34% |
| 2008-12-31 | CN¥1.52 Billion | +20.13% |
| 2007-12-31 | CN¥1.26 Billion | +15.05% |
| 2006-12-31 | CN¥1.10 Billion | +12.62% |
| 2005-12-31 | CN¥975.04 Million | +8.88% |
| 2004-12-31 | CN¥895.55 Million | +15.60% |
| 2003-12-31 | CN¥774.68 Million | +212.14% |
| 2002-12-31 | CN¥248.18 Million | +10.86% |
| 2001-12-31 | CN¥223.88 Million | +25.76% |
| 2000-12-31 | CN¥178.02 Million | -- |
About Zhejiang Huahai Pharmaceutical Co Ltd
Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production and sales of generic drugs, biological drugs, and APIs in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and pol… Read more